Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Short-term Investments: 2009-2018

Historic Short-term Investments for Lifecore Biomedical (LFCR) over the last 7 years, with Nov 2018 value amounting to $1.5 million.

  • Lifecore Biomedical's Short-term Investments rose 66.34% to $1.5 million in Q4 2018 from the same period last year, while for Nov 2018 it was $1.5 million, marking a year-over-year increase of 66.34%. This contributed to the annual value of $1.5 million for FY2018, which is 122.24% up from last year.
  • According to the latest figures from Q4 2018, Lifecore Biomedical's Short-term Investments is $1.5 million, which was up 3.14% from $1.5 million recorded in Q3 2018.
  • Over the past 5 years, Lifecore Biomedical's Short-term Investments peaked at $1.5 million during Q2 2018, and registered a low of $519,000 during Q4 2016.
  • Its 3-year average for Short-term Investments is $1.1 million, with a median of $1.2 million in 2017.
  • Data for Lifecore Biomedical's Short-term Investments shows a peak YoY skyrocketed of 177.65% (in 2018) over the last 5 years.
  • Over the past 3 years, Lifecore Biomedical's Short-term Investments (Quarterly) stood at $519,000 in 2016, then surged by 75.14% to $909,000 in 2017, then surged by 66.34% to $1.5 million in 2018.
  • Its last three reported values are $1.5 million in Q4 2018, $1.5 million for Q3 2018, and $1.5 million during Q2 2018.